Health Care/Hospital

Global Pharmaceutical Contract Manufacturing Organization Market to Reach $102.14 Billion by 2024

Advancements in flexible manufacturing technology to help address new demand in personalized medicine, finds Frost & Sullivan SANTA CLARA, California, Feb. 27, 2020 /PRNewswire/ -- Contract manufacturing organizations (CMOs) are currently transitioning from transactional relationships to strateg...

2020-02-27 01:28 1327

China counters economic fallout from coronavirus

BEIJING, Feb. 26, 2020 /PRNewswire/ -- A news report by China.org.cn on China's economy outlook under the influence of COVID-19:   Lockdowns, travel restrictions, shops and movie theaters closed, business operations delayed, and migrant workers stranded in their hometowns. These...

2020-02-26 22:00 1156

Optoelectronic Technologies Assisting in the Fight Against COVID-19

SHENZHEN, China, Feb. 26, 2020 /PRNewswire/ -- Optoelectronic technologies benefit our daily lives from every aspect. However less people know that optoelectronic technologies are playing a key role amid the fight against COVID-19, especially for technologies such as information and communication...

2020-02-26 16:57 2098

Enso Partners with My Life Centre to Open 2 More ECP Centres

KUALA LUMPUR, Malaysia, Feb. 26, 2020 /PRNewswire/ -- Enso S&A Health House Sdn. Bhd. (Enso) has just enter into a partnership with My Life Centre (MLC) to open 2 more new ECPCentres in Johor Bahru & Kota Bahru for alternative medicine and therapy. Approximately 3 months ago, Enso took over "The ...

2020-02-26 16:30 4338

The Animal Health & Feed Zone of CPhI China 2020 to be held in Shanghai

SHANGHAI, Feb. 26, 2020 /PRNewswire/ -- The Animal Health & Feed Zone of CPhI China to be held at the Shanghai New International Expo Centre (SNIEC) fromJune 22-24, 2020 will focus on top concerns of animal health enterprises.  90% of the total antibiotics in the world are consumed in food-source...

2020-02-26 11:49 1850

KAHR Medical Raises $18 Million in Private Funding Round

Funds will be used for advancing the Company's next generation immuno-oncology drug candidates, including lead anti-CD47 product for the treatment of solid tumors through Phase I/II study in addition to advancing preclinical pipeline JERUSALEM, Feb. 26, 2020 /PRNewswire/ -- KAHR Medical

2020-02-26 08:30 2412

Trip.com Announces Safeguards for Travelers Affected by COVID-19 Outbreak

SHANGHAI, Feb. 26, 2020 /PRNewswire/ -- In light of the ongoing impact of the COVID-19 outbreak, Trip.com today announced an expansion to its Safeguard Cancellation Guarantee. Originally announced in January with the support of industry partners, the Trip.com Safeguard Cancellation Guarantee ini...

2020-02-26 01:44 1814

New Data Confirms Cardiac Dimensions' Carillon® System Shows Favorable Long-Term Survival Rate In Patients With Functional Mitral Regurgitation

Pooled Analysis of Prospective Studies Presented during Late Breaking Trials Session at CRT 2020 KIRKLAND, Washington, Feb. 25, 2020 /PRNewswire/ -- Cardiac Dimensions, a leader in the development of innovative, minimally invasive treatments for functional mitral regurgitation (FMR) in patients ...

2020-02-26 00:50 1076

WuXi Biologics and Vir Biotechnology Announce Collaboration for Global Development of Antibodies to Treat COVID-19

SAN FRANCISCO and SHANGHAI, Feb. 25, 2020 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a leading global open-access biologics technology platform company offering end-to-end solutions for biologics discovery, development and manufacturing, and Vir Biotechnology, Inc. ("Vir") (Nasdaq: VI...

2020-02-25 21:30 2287

China Xiangtai Food Co., Ltd. Entered into Business Collaboration Agreement for up to RMB35,000,000 to Expand Operation Scale and Diversify Distribution Channels

CHONGQING, China, Feb. 25, 2020 /PRNewswire/ -- China Xiangtai Food Co. Ltd. (NASDAQ: PLIN) (the "Company" or the "PLIN"), an emerging growth company primarily engaged in pork processing inChina, today announced that the Company, through its primary operating subsidiary Chongqing Penglin Food Co....

2020-02-25 21:30 5790

Connect Biopharma Enhances its Intellectual Property Estate for CBP-307, a Targeted Therapy with Potential in Multiple Autoimmune Diseases, with Patent Issuances in the United States, EU, Japan and Australia

Novel, next-generation S1P1 agonist currently in Phase 2 clinical development for treatment of inflammatory bowel disease SAN DIEGO and TAICANG, China, Feb. 25, 2020 /PRNewswire/ -- Connect Biopharma, a clinical-stage biopharmaceutical company focused on identifying and developing potent and spe...

2020-02-25 21:00 911

United Imaging's Emergency Radiology Departments Support Mobile Cabin Hospitals, Facilitate 5G Remote Diagnosis

SHANGHAI, Feb. 25, 2020 /PRNewswire/ -- At the center of the epidemic in Wuhan, many sports centers, exhibition halls, and schools have been turned into mobile cabin hospitals (MCHs) to treat tens of thousands of coronavirus patients with mild symptoms. During the epidemic, fast and accurate CT d...

2020-02-25 21:00 1632

ACT Continues to Send Aid to Various Countries to Face Coronavirus Outbreak

JAKARTA, Indonesia, Feb. 25, 2020 /PRNewswire/ -- After collaborating with various partners, including the international NGO Peace Wind Japan (PWJ), until now,Aksi Cepat Tanggap (ACT) has sent 1,610 boxes of the masks. 1,210 boxes were sent toHong Kong, 300 boxes to Taiwan, and 100 boxes to Singa...

2020-02-25 15:55 1862

InDex Pharmaceuticals Publishes Mechanism of Action Data for Cobitolimod in Scientific Journal

STOCKHOLM, Feb. 25, 2020 /PRNewswire/ -- InDex Pharmaceuticals Holding AB (publ) today announced the publication of scientific data on the mechanism of action of cobitolimod, the company's lead drug candidate in development for the treatment of moderate to severe ulcerative colitis. The paper, pu...

2020-02-25 15:26 1076

Manulife Singapore Commits S$1 Million to Provide Additional COVID-19 Protection Benefits for Customers

SINGAPORE, Feb. 25, 2020 /PRNewswire/ -- In support of the Singapore government 's effort in dealing with the evolving C0VID-19 situation, Manulife Singapore has enhanced its protection coverage for all customers. In these challenging times of...

2020-02-25 12:27 3607

GM Pharm announces health items for sale on Rakuten, popular items featured

SEOUL, South Korea, Feb. 25, 2020 /PRNewswire/ -- GM Pharm announced that it would be selling popular items on Rakuten for a 20% discount. Included in the sales list are The Probiotics for Woman, The rTG Omega-3, The Folic for Daddy, and The Folic for Mommy.

2020-02-25 09:30 2256

Maybank and Etiqa Singapore offer complimentary COVID-19 and dengue fever special insurance coverage to all customers

SINGAPORE, Feb. 25, 2020 /PRNewswire/ -- In light of the on-going threat of the Coronavirus Disease 2019 (COVID-19) and recent developments and rise of dengue fever cases inSingapore, Maybank and its insurance arm Etiqa Singapore are stepping up and pledging to provide a 30-day special insurance ...

2020-02-25 08:23 3417

Those Who Believe They Have a Claim Against Purdue Must File a Proof of Claim by the Bar Date: June 30, 2020

NEW YORK, Feb. 25, 2020 /PRNewswire/ -- The following is being issued by Prime Clerk. What is this about? Purdue Pharma L.P., a U.S. limited partnership, its general partner and its subsidiaries, including Imbrium Therapeutics L.P., Adlon Therapeutics L.P., Greenfield BioVentures L.P., Avrio He...

2020-02-25 02:15 1160

U.S. FDA accepts GSK's sNDA application for Zejula (niraparib) for first-line maintenance treatment for women with platinum-responsive advanced ovarian cancer

-  Submission based on data from the Phase III PRIMA clinical study that demonstrated clinically-meaningful outcomes of niraparib maintenance treatment in the first-line setting regardless of biomarker status -  The application is being reviewed under the FDA's Real-Time Oncology Review pilot pr...

2020-02-24 22:00 1179

Ascentage Pharma Announces Approval for the Phase Ib/II Clinical Trial of APG-1387 in Combination with Chemotherapy for the Treatment of Advanced Pancreatic Cancer in China

SUZHOU, China and ROCKVILLE, MD., Feb. 24, 2020 /PRNewswire/ -- Ascentage Pharma (6855.HK), a globally-focused, clinical-stage biotechnology company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today announced that the company has receive...

2020-02-24 22:00 2191
1 ... 720721722723724725726 ... 807